Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways
Mário Šereš,
No information about this author
Katarina Spacayova,
No information about this author
Zdena Sulová
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(2), P. 248 - 248
Published: Jan. 14, 2025
The
epidermal
growth
factor
receptor
(EGFR)
regulates
gene
expression
through
two
primary
mechanisms:
as
a
in
the
nucleus,
where
it
translocates
upon
binding
its
ligand,
or
via
intrinsic
tyrosine
kinase
activity
cytosol,
modulates
key
signaling
pathways
such
RAS/MYC,
PI3K,
PLCγ,
and
STAT3.
During
tumorigenesis,
these
become
deregulated,
leading
to
uncontrolled
proliferation,
enhanced
migratory
metastatic
capabilities,
evasion
of
programmed
cell
death,
resistance
chemotherapy
radiotherapy.
RAS
MYC
oncogenes
are
pivotal
driving
processes
apoptosis,
replicative
immortality,
cellular
invasion
metastasis,
metabolic
reprogramming.
These
subject
regulation
by
range
epigenetic
post-transcriptional
modifications.
This
review
focuses
on
deregulation
EGFR,
RAS,
caused
(epi)genetic
alterations
post-translational
It
also
explores
therapeutic
potential
targeting
regulatory
proteins,
emphasizing
importance
phenotyping
neoplastic
tissues
inform
treatment
cancer.
Language: Английский
Fingerprint of ubiquitin coupled enzyme UBC13 in health and disease
Ru-Yi Chen,
No information about this author
Yanjun Liu,
No information about this author
Ran Wang
No information about this author
et al.
Bioorganic Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 108524 - 108524
Published: April 1, 2025
Language: Английский
Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review
Chang Gao,
No information about this author
Yanjun Liu,
No information about this author
Jing Yu
No information about this author
et al.
Cells,
Journal Year:
2024,
Volume and Issue:
14(1), P. 15 - 15
Published: Dec. 26, 2024
Ubiquitin-conjugating
enzyme
E2
T
(UBE2T)
is
a
crucial
in
the
ubiquitin-proteasome
system
(UPS),
playing
significant
role
ubiquitination
of
proteins
and
influencing
wide
range
cellular
processes,
including
proliferation,
differentiation,
apoptosis,
invasion,
metabolism.
Its
overexpression
has
been
implicated
various
malignancies,
such
as
lung
adenocarcinoma,
gastric
cancer,
pancreatic
liver
ovarian
where
it
correlates
strongly
with
disease
progression.
UBE2T
facilitates
tumorigenesis
malignant
behaviors
by
mediating
essential
functions
DNA
repair,
cell
cycle
regulation,
activation
oncogenic
signaling
pathways.
High
levels
expression
are
associated
poor
survival
outcomes,
highlighting
its
potential
molecular
biomarker
for
cancer
prognosis.
Increasing
evidence
suggests
that
acts
an
oncogene
could
serve
promising
therapeutic
target
treatment.
This
review
aims
to
provide
detailed
overview
UBE2T’s
structure,
functions,
mechanisms
involved
progression
well
recent
developments
UBE2T-targeted
inhibitors.
Such
insights
may
pave
way
novel
strategies
diagnosis
treatment,
enhancing
our
understanding
biology
supporting
development
innovative
approaches.
Language: Английский
Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 31, 2024
Lung
cancer
(LC)
is
one
of
the
most
common
worldwide.
Tumor-associated
macrophages
(TAMs)
are
important
component
tumor
microenvironment
(TME)
and
closely
related
to
stages
occurrence,
development,
metastasis.
Macrophages
plastic
can
differentiate
into
different
phenotypes
functions
under
influence
signaling
pathways
in
TME.
The
classically
activated
(M1-like)
alternatively
(M2-like)
represent
two
polarization
states
macrophages.
M1
exhibit
anti-tumor
functions,
while
M2
considered
support
cell
survival
Macrophage
involves
complex
pathways,
blocking
or
regulating
these
enhance
macrophages'
effects
has
become
a
research
hotspot
recent
years.
At
same
time,
there
have
been
new
discoveries
regarding
modulation
TAMs
towards
an
phenotype
by
synthetic
natural
drug
components.
Nanotechnology
better
achieve
combination
therapy
targeted
delivery
drugs,
maximizing
efficacy
drugs
minimizing
side
effects.
Up
now,
nanomedicines
targeting
various
active
substances
for
reprogramming
made
significant
progress.
In
this
review,
we
primarily
provided
comprehensive
overview
crosstalk
between
cells
LC
microenvironment.
Additionally,
latest
advancements
novel
nano-based
systems
(NDDSs)
that
target
were
also
reviewed.
Finally,
discussed
prospects
as
therapeutic
targets
barriers
clinical
translation.
Language: Английский